These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37622525)

  • 1. Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress-induced Parkinson's disease susceptibility.
    Lin XM; Pan MH; Sun J; Wang M; Huang ZH; Wang G; Wang R; Gong HB; Huang RT; Huang F; Sun WY; Liu HZ; Kurihara H; Li YF; Duan WJ; He RR
    Aging Cell; 2023 Oct; 22(10):e13970. PubMed ID: 37622525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation.
    Jiang YN; Guo YZ; Lu DH; Pan MH; Liu HZ; Jiao GL; Bi W; Kurihara H; Li YF; Duan WJ; He RR; Yao XS
    J Ethnopharmacol; 2020 Jun; 256():112824. PubMed ID: 32259664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition.
    Mahoney-Sanchez L; Bouchaoui H; Boussaad I; Jonneaux A; Timmerman K; Berdeaux O; Ayton S; Krüger R; Duce JA; Devos D; Devedjian JC
    Cell Rep; 2022 Aug; 40(8):111231. PubMed ID: 36001957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons.
    Sun J; Lin XM; Lu DH; Wang M; Li K; Li SR; Li ZQ; Zhu CJ; Zhang ZM; Yan CY; Pan MH; Gong HB; Feng JC; Cao YF; Huang F; Sun WY; Kurihara H; Li YF; Duan WJ; Jiao GL; Zhang L; He RR
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
    Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
    Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
    Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons.
    Bouchaoui H; Mahoney-Sanchez L; Garçon G; Berdeaux O; Alleman LY; Devos D; Duce JA; Devedjian JC
    Free Radic Biol Med; 2023 Feb; 195():145-157. PubMed ID: 36581060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
    Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
    J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
    Zhang S; Eitan E; Wu TY; Mattson MP
    Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
    Caudal D; Alvarsson A; Björklund A; Svenningsson P
    Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanism.
    Ghosh S; Won SJ; Wang J; Fong R; Butler NJM; Moss A; Wong C; Pan J; Sanchez J; Huynh A; Wu L; Manfredsson FP; Swanson RA
    Prog Neurobiol; 2021 Jul; 202():102070. PubMed ID: 33951536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.